Identification of optimal combinations for empirical dual antimicrobial therapy of pseudomonas aeruginosa infection: Potential role of a combination antibiogram

被引:165
作者
Mizuta, Mari
Linkin, Darren R.
Nachamkin, Irving
Fishman, Neil O.
Weiner, Mark G.
Sheridan, Angela
Lautenbach, Ebbing
机构
[1] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Div Infect Dis, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Div Gen Internal Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Med, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[6] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Pathol, Philadelphia, PA 19104 USA
[7] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Lab Med, Philadelphia, PA 19104 USA
[8] Univ Penn, Sch Med, Ctr Educ & REs Therapeut, Philadelphia, PA 19104 USA
关键词
D O I
10.1086/503175
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
To better determine the optimal combinations for empirical dual antimicrobial therapy of Pseudomonas aeruginosa infection, we evaluated the utility of a novel combination antibiogram. Although the combination antibiogram allowed modest fine-tuning of choices for dual antibiotic therapy, selections based on the 2 antibiograms did not differ substantively. Drug combinations with the broadest coverage were consistently composed of an aminoglycoside and a beta-lactam.
引用
收藏
页码:413 / 415
页数:3
相关论文
共 17 条
[1]   Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit [J].
AlvarezLerma, F ;
Pellus, AM ;
Sanchez, BA ;
Ortiz, EP ;
Jorda, R ;
Barcenilla, F ;
Maravi, E ;
Galvan, B ;
Palomar, M ;
Serra, J ;
Bermejo, B ;
Mateu, A ;
Quintana, E ;
Palacios, MS ;
Giral, R ;
Gonzalez, V ;
Lerma, FA ;
Mesa, JL ;
Melgarejo, JA ;
Martinez, J ;
Insausti, J ;
Olaechea, P ;
Chanovas, M ;
Gilabert, A ;
Junquera, C ;
Valles, J ;
Palacios, F ;
Calvo, R ;
Mesalles, E ;
Nava, J ;
Santos, A ;
Armengol, S ;
Marzo, D .
INTENSIVE CARE MEDICINE, 1996, 22 (05) :387-394
[2]   Antibiotic resistance in Pseudomonas aeruginosa:: an Italian survey [J].
Bonfiglio, G ;
Carciotto, V ;
Russo, G ;
Stefani, S ;
Schito, GC ;
Debbia, E ;
Nicoletti, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (02) :307-310
[3]   Pseudomonas aeruginosa:: a survey of resistance in 136 hospitals in Spain [J].
Bouza, E ;
Garcia-Garrote, F ;
Cercenado, E ;
Marin, M ;
Diaz, MS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :981-982
[4]   EPIDEMIOLOGY OF DRUG-RESISTANCE - IMPLICATIONS FOR A POSTANTIMICROBIAL ERA [J].
COHEN, ML .
SCIENCE, 1992, 257 (5073) :1050-1055
[5]   Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data? [J].
Ernst, EJ ;
Diekema, DJ ;
BootsMiller, BJ ;
Vaughn, T ;
Yankey, JW ;
Flach, SD ;
Ward, MM ;
Franciscus, CLJ ;
Acosta, E ;
Pfaller, MA ;
Doebbeling, BN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 49 (02) :141-145
[6]   Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002 [J].
Flamm, RK ;
Weaver, MK ;
Thornsberry, C ;
Jones, ME ;
Karlowsky, JA ;
Sahm, DF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (07) :2431-2436
[7]   Antimicrobial resistance in European isolates of Pseudomonas aeruginosa [J].
Fluit, AC ;
Verhoef, J ;
Schmitz, FJ .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (05) :370-374
[8]   Phenotypic antimicrobial resistance patterns in Pseudomonas aeruginosa and Acinetobacter:: results of a Multicenter Intensive Care Unit Surveillance Study, 1995-2000 [J].
Friedland, I ;
Stinson, L ;
Ikaiddi, M ;
Harm, S ;
Woods, GL .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 45 (04) :245-250
[9]  
HOLMBERG SD, 1987, REV INFECT DIS, V9, P1065
[10]   The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting [J].
Ibrahim, EH ;
Sherman, G ;
Ward, S ;
Fraser, VJ ;
Kollef, MH .
CHEST, 2000, 118 (01) :146-155